Veterinary Medicines

NEO ENTEROFARMA, polvere orale per vitelli neonati

Not authorised
  • Paromomycin
  • Phthalylsulfathiazole
  • Dihydrostreptomycin sulfate
Download as PDF

Product identification

Medicine name:
NEO ENTEROFARMA, polvere orale per vitelli neonati
Active substance:
  • Paromomycin
  • Phthalylsulfathiazole
  • Dihydrostreptomycin sulfate
Target species:
  • Cattle (suckling calf)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Paromomycin
    10.00
    milligram(s)
    /
    1.00
    gram(s)
  • Phthalylsulfathiazole
    60.00
    milligram(s)
    /
    1.00
    gram(s)
  • Dihydrostreptomycin sulfate
    25.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral powder
Withdrawal period by route of administration:
  • Oral use
    • Cattle (suckling calf)
      • Meat and offal
        35
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA99
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Salute Animale S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
  • Vetem SPA
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 14/06/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."